Kimberly Manhard, SVP, Regulatory & Development Operations at Ardea Biosciences, Inc./DE (RDEA), sold 5,000 shares at $18.01 ($90K) on 2012-01-30, disclosed to the SEC on 2012-01-31.
Scheduled sale ($90k) by SVP, Regulatory & Development Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| INBX | BUY | 2024-08-30 | $140K | — | Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |